This online, self-paced, text-based module explores common nomenclature in pharmacogenomics (PGx).
It was developed by the National Human Genome Research Institute (NHGRI) Inter-Society Coordinating Committee for Practitioner Education in Genomics (ISCC-PEG).
To access, log in to our site (to right of this page; free registration) and enroll using one of the following methods: - Free for all learners (via self-enrollment below) - For continuing education credit (requires small fee; click 'Pay Now' below)
Faculty
Planning Committee for the ISCC-PEG Pharmacogenomics Learning Series:
Philip Empey, PharmD, PhD, FCCP (University of Pittsburgh School of Pharmacy)
Christina Aquilante, PharmD, Director of Pharmacogenomics for the Colorado Center for Personalized Medicine; Professor, Department of Pharmaceutical Sciences; University of Colorado
Kathy Giacomini, PhD, Dean and Professor, School of Pharmacy; Co-Director UCSF-Stanford Center of Excellence in Regulatory Sciences and Innovation; University of California, San Francisco
Course details
TARGET AUDIENCE
All healthcare professionals
LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to:
Review the nomenclature for PGx
Review available evidence sources for pharmacogenomic recommendations.
Describe how Clinical Pharmacogenetic Implementation Consortium (CPIC) guidelines are developed, the components of a CPIC guideline and how CPIC guidelines can be used by clinicians to make specific prescribing decisions for patient care.
Retrieve the levels of evidence for gene/drug pairs.
Integrate information from US Food and Drug Administration (FDA), CPIC, and PharmGKB into pharmacogenomic clinical decision making.
This online, self-paced, text-based module educates healthcare professionals about evidence-based pharmacogenomic resources from the Food & Drug Administration (FDA), the Clinical Pharmacogenetics Implementation Consortium (CPIC), and the Pharmacogenomics Knowledgebase (PharmGKB).
It was developed by the National Human Genome Research Institute (NHGRI) Inter-Society Coordinating Committee for Practitioner Education in Genomics (ISCC-PEG).
To access, log in to our site (to right of this page; free registration) and enroll using one of the following methods: - Free for all learners (via self-enrollment below) - For continuing education credit (requires small fee; click 'Pay Now' below)
Faculty
Planning Committee for the ISCC-PEG Pharmacogenomics Learning Series:
Philip Empey, PharmD, PhD, FCCP (University of Pittsburgh School of Pharmacy)
Philip Empey, PharmD, PhD Associate Professor and Director, Pharmacogenomics Center of Excellence University of Pittsburgh School of Pharmacy
Benjamin Brown American Society of Pharmacovigilance
Additional Content Reviewers
Kelly Caudle, PharmD, PhD, Director, Clinical Pharmacogenetics Implementation Consortium
Wendy Rubinstein, MD, PhD, Director, Personalized Medicine, Food & Drug Administration (Questions 1 and 3 only). The review does not constitute an endorsement by FDA or any of its employees
Course details
TARGET AUDIENCE
All healthcare professionals
LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to:
Review available evidence sources for pharmacogenomic recommendations.
Describe the components of a CPIC guideline and how CPIC guidelines can be used by clinicians to make specific prescribing decisions for patient care.
Explain how evidence-based guidelines are developed by CPIC.
Retrieve the levels of evidence for gene/drug pairs.
Integrate information from FDA, CPIC, and PharmGKB into pharmacogenomic clinical decision making.
This online, self-paced, text-based module educates healthcare professionals about what elements are involved in implementing a simple population-focused, pharmacogenomic program.
It was developed by the National Human Genome Research Institute (NHGRI) Inter-Society Coordinating Committee for Practitioner Education in Genomics (ISCC-PEG).
To access, log in to our site (to right of this page; free registration) and enroll using one of the following methods: - Free for all learners (via self-enrollment below) - For continuing education credit (requires small fee; click 'Pay Now' below)
Faculty
Planning Committee for the ISCC-PEG Pharmacogenomics Learning Series:
Philip Empey, PharmD, PhD, FCCP (University of Pittsburgh School of Pharmacy)
Otito Frances Iwuchukwu, PhD, MA Associate Professor Fairleigh Dickinson University
Jenny Nguyen, PharmD, APh, BCPS Clinical Pharmacogenomics Specialist Children's Hospital Los Angeles
Additional Content Reviewers
Natasha Petry, PharmD, BCACP, Associate Professor, North Dakota State University and Sanford Health Imagenetics
Vivian K. Kawai MD, MPH, Director of Pharmacogenomics, Vanderbilt University School of Medicine
Course details
TARGET AUDIENCE
All healthcare professionals
LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to:
Describe the components and practical aspects of standard pharmacogenomics implementation.
Identify the roles of various healthcare professionals in implementation teams.
Evaluate curated examples of successful implementation programs in different practice settings.
Apply model principles of pharmacogenomics implementation using a familiar and readily implementable gene-drug or gene-disease pair case example for a clinical practice (or system).
This online, self-paced, text-based module educates healthcare professionals towards a better understanding of the benefits and limitations of direct-to-consumer pharmacogenomic testing, when to pursue confirmatory clinical testing, and how to interpret pharmacogenomic test results using evidence-based resources.
It was developed by the National Human Genome Research Institute (NHGRI) Inter-Society Coordinating Committee for Practitioner Education in Genomics (ISCC-PEG).
To access, log in to our site (to right of this page; free registration) and enroll using one of the following methods: - Free for all learners (via self-enrollment below) - For continuing education credit (requires small fee; click 'Pay Now' below)
Faculty
Planning Committee for the ISCC-PEG Pharmacogenomics Learning Series:
Philip Empey, PharmD, PhD, FCCP (University of Pittsburgh School of Pharmacy)